[Latest] Global Cancer Supportive Care Drugs Market Size/Share Worth USD 32,783.2 Billion by 2033 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
06. Mai 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Supportive Care Drugs Market Size, Trends and Insights By Drug Type...
Biosimilars Market is Projected to Reach an Estimate of $143.6 Billion by 2031, with CAGR of 24.7% : Allied Market Research
26. Oktober 2023 07:35 ET
|
Allied Market Research
Wilmington, Delaware, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Allied Market Research released a report, titled, “Biosimilars Market by Type (Erythropoietin, Human growth hormone, Monoclonal antibodies,...
Global Erythropoietin (EPO) Drugs Market Analysis Report 2023-2031: Rising Prevalence of CKD, Growing Use in Oncology, Drug Delivery Advancements, & Biosimilars and Patent Expirations, Key to Growth
04. September 2023 05:37 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Erythropoietin Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. In the dynamic...
Global Erythropoietin (EPO) Drugs Market Analysis Report 2023-2031: Rising Prevalence of CKD, Growing Use in Oncology, Drug Delivery Advancements, & Biosimilars and Patent Expirations, Key to Growth
04. September 2023 05:34 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Erythropoietin Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. In the dynamic...
Global Erythropoietin Drugs Market Report 2023: Sector is Expected to Reach $7.8 Billion by 2030 at a CAGR of 1.5%
15. Mai 2023 11:33 ET
|
Research and Markets
Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Erythropoietin Drugs Market Size, Share & Trends Analysis Report By Type (Biologics, Biosimilars) By Product (Erythropoietin, Darbepoetin-alfa), By...
Global PEGylated Proteins Market Analysis & Industry Trends Report 2022: A $2.1 Billion Market by 2028 - Focus on Colony-stimulating Factor, Interferons, Recombinant Factor VII, & Erythropoietin
22. März 2023 10:13 ET
|
Research and Markets
Dublin, March 22, 2023 (GLOBE NEWSWIRE) -- The "Global PEGylated Proteins Market Size, Share & Industry Trends Analysis Report By Product & Services, By Type (Colony-stimulating Factor,...
Insights on the Erythropoietin Drugs Global Market to 2027 - by Drug Class, Product Type, Application, End-user and Region
17. Januar 2023 05:08 ET
|
Research and Markets
Dublin, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The "Erythropoietin Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Biopharmaceutical Market to Generate USD 974.48 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
02. August 2022 06:41 ET
|
Next Move Strategy Consulting
New York, Aug. 02, 2022 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the global biopharmaceutical market generated USD 345.84 billion in 2021, and is...
Global Downstream Processing Market is Expected to Reach $92.0 Billion by 2030: Says AMR
07. Juli 2022 20:00 ET
|
Allied Market Research
Portland, OR, July 07, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Downstream Processing Market was estimated at $21.8 billion in 2020 and is...
Global $3.11 Bn Erythropoietin (EPO) Markets, 2015-2020, 2020-2025F, 2030F Featuring Amgen, Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion, and LG Life Sciences
21. Dezember 2021 05:53 ET
|
Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...